Author:
Allen Caitlin G.,Sugarman Michael A.,Wennerstrom Ashley
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Health (social science)
Reference48 articles.
1. IMS Health. Top Theraputic Classes by U.S. Spending. IMS. Available online at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/Press Room/Top_line_data/Top_Therapy_Classes_by_Sales.pdf. Accessed September 22, 2015.
2. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Mededicine 2005;353(12):1209–1223.
3. Lage MJ, Hassan MK. The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study. Annals of General Psychiatry 2009;8:7.
4. Subotnik KL, Nuechterlein KH, Ventura J, et al. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. American Journal of Psychiatry 2011;168(3):286–292.
5. Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services 2001;52(6):805–811.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献